Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Deloitte
Colorcon
Express Scripts
Julphar
Merck
Boehringer Ingelheim
Chinese Patent Office
Accenture

Generated: October 21, 2017

DrugPatentWatch Database Preview

TYLENOL W/ CODEINE NO. 1 Drug Profile

« Back to Dashboard

Which patents cover Tylenol W/ Codeine No. 1, and what generic Tylenol W/ Codeine No. 1 alternatives are available?

Tylenol W/ Codeine No. 1 is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in TYLENOL W/ CODEINE NO. 1 is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.

Summary for Tradename: TYLENOL W/ CODEINE NO. 1

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Clinical Trials: see list249
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TYLENOL W/ CODEINE NO. 1 at DailyMed

Pharmacology for Tradename: TYLENOL W/ CODEINE NO. 1

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
TYLENOL W/ CODEINE NO. 1
acetaminophen; codeine phosphate
TABLET;ORAL085055-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Citi
Johnson and Johnson
Accenture
Queensland Health
Mallinckrodt
Chinese Patent Office
QuintilesIMS
Fish and Richardson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot